Trial intelligence / Profile preview

Ketamine for pain control in severe traumatic injury

NCT04274361Completed

Sponsor
Medical College of Wisconsin
Start
Jan 2021
Primary completion
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in pain comparing Ketamine arm with Placebo arm (2 arms). Primary endpoint: Cumulative opioid morphine equivalent dose at 24 hours. Started Jan 2021; status: completed.

02

Drugs

ketamine
03

Conditions

pain

Beyond the preview

Go deeper on NCT04274361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04274361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call